furazolidone has been researched along with Indigestion in 11 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to explore the optimal regimens for the eradication of Helicobacter pylori (Hp), eighty-eight patients with duodenal ulcer (DU) or non-ulcer dyspepsia and Hp infection, defined by culture and histology, received the one-week triple therapy with clarithromycin (Cla), furazolidone (Fur) plus lansoprazole (Lan) or colloidal bismuth subcitrate (CBS)." | 5.08 | [Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection]. ( Liu, W; Lü, B; Xiao, S, 1996) |
| " pylori) is complex; full effectiveness is rarely achieved and it has many adverse effects." | 2.78 | Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. ( Barbuti, RC; Bogsan, CS; Chinzon, D; de Oliveira, MN; Eisig, JN; Mattar, R; Moraes-Filho, JP; Navarro-Rodriguez, T; Silva, FM, 2013) |
| "A urea breath test was performed 1-2 months after eradication." | 2.71 | Eradication rate of Helicobacter pylori in dyspeptic patients. ( Amini, M; Khedmat, H; Yari, F, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navarro-Rodriguez, T | 1 |
| Silva, FM | 1 |
| Barbuti, RC | 1 |
| Mattar, R | 1 |
| Moraes-Filho, JP | 1 |
| de Oliveira, MN | 1 |
| Bogsan, CS | 1 |
| Chinzon, D | 1 |
| Eisig, JN | 1 |
| COLOMBO, ML | 1 |
| HAGGENMUELLER, F | 1 |
| BOEHM, C | 1 |
| Qasim, A | 1 |
| Sebastian, S | 1 |
| Thornton, O | 1 |
| Dobson, M | 1 |
| McLoughlin, R | 1 |
| Buckley, M | 1 |
| O'Connor, H | 1 |
| O'Morain, C | 1 |
| Amini, M | 1 |
| Khedmat, H | 1 |
| Yari, F | 1 |
| Gisbert, JP | 1 |
| Liu, W | 1 |
| Lü, B | 1 |
| Xiao, S | 1 |
| Liu, WZ | 1 |
| Xiao, SD | 1 |
| Shi, Y | 1 |
| Wu, SM | 1 |
| Zhang, DZ | 1 |
| Xu, WW | 1 |
| Tytgat, GN | 1 |
| Mendonça, S | 1 |
| Ecclissato, C | 1 |
| Sartori, MS | 1 |
| Godoy, AP | 1 |
| Guerzoni, RA | 1 |
| Degger, M | 1 |
| Pedrazzoli, J | 1 |
| Fakheri, H | 1 |
| Malekzadeh, R | 1 |
| Merat, S | 1 |
| Khatibian, M | 1 |
| Fazel, A | 1 |
| Alizadeh, BZ | 1 |
| Massarrat, S | 1 |
| Zholudov, VP | 1 |
5 trials available for furazolidone and Indigestion
| Article | Year |
|---|---|
Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Brazil; Disease Eradication; Double- | 2013 |
Eradication rate of Helicobacter pylori in dyspeptic patients.
Topics: Analysis of Variance; Anti-Bacterial Agents; Breath Tests; Ciprofloxacin; Drug Therapy, Combination; | 2005 |
[Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithrom | 1996 |
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; | 1999 |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithr | 2001 |
6 other studies available for furazolidone and Indigestion
| Article | Year |
|---|---|
[Furazolidone in the treatment of gastro-intestinal diseases in infants].
Topics: Child; Dyspepsia; Furazolidone; Gastroenteritis; Gastrointestinal Diseases; Humans; Infant; Intestin | 1960 |
[Clinical report on the treatment of dyspepsia in infancy. I].
Topics: Dyspepsia; Escherichia coli Infections; Furazolidone; Humans; Infant Nutrition Disorders; Polymyxins | 1962 |
Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Fem | 2005 |
How effective are rescue H. pylori eradication therapies in patients with dyspepsia?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Drug Therapy, Combination | 2005 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Brazil; Drug Resistance, Microbial; Dru | 2000 |
[The therapeutic effect of antimicrobial preparations in calf dyspepsia].
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Cattle; Cattle Diseases; Chloramphenicol; Chlortet | 1971 |